Frequent epigenetic alterations in polycomb repressive complex 2 in osteosarcoma cell lines.

about

Frequent epigenetic alterations in polycomb repressive complex 2 in osteosarcoma cell lines.

Item

http://www.wikidata.org/entity/Q55261902

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Frequent epigenetic alteration ...... 2 in osteosarcoma cell lines.

@en

Frequent epigenetic alteration ...... 2 in osteosarcoma cell lines.

@nl

type

Item

label

Frequent epigenetic alteration ...... 2 in osteosarcoma cell lines.

@en

Frequent epigenetic alteration ...... 2 in osteosarcoma cell lines.

@nl

prefLabel

Frequent epigenetic alteration ...... 2 in osteosarcoma cell lines.

@en

Frequent epigenetic alteration ...... 2 in osteosarcoma cell lines.

@nl

P1476

Frequent epigenetic alteration ...... x 2 in osteosarcoma cell lines

@en

P2093

Andrew M Davidoff

http://www.w3.org/2001/XMLSchema#string

Gang Wu

http://www.w3.org/2001/XMLSchema#string

Helin Feng

http://www.w3.org/2001/XMLSchema#string

Jun Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells

Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

EZH2 as a mediator of treatment resistance in melanoma

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

The Polycomb complex PRC2 and its mark in life

Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.

P304

27087-27091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25484

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heather S Tillman

P577

2018-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29930752

http://www.w3.org/2001/XMLSchema#string

P932

6007463

http://www.w3.org/2001/XMLSchema#string